Amgen Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $1.98B | $7.72B | $6.94B | $5.16B | $5.08B | $4.35B | $3.68B | $4.63B |
| Depreciation & Amortization | $1.96B | $2.11B | $2.11B | $2.09B | $1.29B | $1.09B | $1.06B | $1.02B |
| Depreciation | $604.0M | $619.0M | $727.0M | $716.0M | $644.0M | $689.0M | $679.0M | $594.0M |
| Amortization | $1.30B | $1.50B | $1.40B | $1.40B | $642.0M | $397.0M | $380.0M | $423.0M |
| Stock-Based Compensation | $329.0M | $311.0M | $322.0M | $408.0M | $403.0M | $362.0M | $341.0M | $353.0M |
| Net Cash from Operating Activities | $11.18B | $10.35B | $9.73B | $8.95B | $6.29B | $5.88B | $5.12B | $5.79B |
| Investing Activities | ||||||||
| Capital Expenditures | $664.0M | $738.0M | $594.0M | $718.0M | $693.0M | $689.0M | $567.0M | $580.0M |
| Business Acquisitions | $19.0M | $0 | $359.0M | $165.0M | $9.43B | $2.39B | $701.0M | $0 |
| Net Cash from Investing Activities | $-4.02B | $-8.66B | $-5.55B | $-5.75B | $-8.47B | $-9.99B | $-786.0M | $-4.15B |
| Financing Activities | ||||||||
| Dividends Paid | $3.37B | $3.00B | $2.40B | $1.85B | $1.42B | $1.12B | $500.0M | $0 |
| Stock Repurchases | $3.16B | $2.97B | $1.87B | $138.0M | $832.0M | $4.61B | $8.32B | $3.79B |
| Net Cash from Financing Activities | $-6.59B | $-2.60B | $-3.77B | $-3.27B | $2.73B | $419.0M | $-674.0M | $-1.23B |
| Net Change in Cash | $559.0M | $-903.0M | $413.0M | $-74.0M | $548.0M | $-3.69B | $3.66B | $403.0M |
| Free Cash Flow | $10.51B | $9.62B | $9.14B | $8.23B | $5.60B | $5.19B | $4.55B | $5.21B |